Presentation Details:
Dr. Joanne Stekler reviews the data for injectable lenacapavir as HIV pre-exposure prophylaxis (PrEP) to date, and potential considerations for lenacapavir use as PrEP, if it is approved for that indication in the future.
Presentation Transcript: